TRVI - Trevi Therapeutics Inc. (TRVI) Q4 2023 Earnings Call Transcript
2024-03-20 18:21:10 ET
Trevi Therapeutics, Inc. (TRVI)
Q4 2023 Earnings Conference Call
March 20, 2024 04:30 PM ET
Company Participants
Jennifer Good - President & CEO
Lisa Delfini - CFO
David Clark - Chief Medical Officer
Conference Call Participants
Leland Gershell - Oppenheimer
Serge Belanger - Needham & Company
Presentation
Operator
Good afternoon, and welcome to the Trevi Therapeutics Fourth Quarter and Year-End 2023 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.
Various remarks that management makes during this conference call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent quarterly report on Form 10-K, which the company filed with the SEC this afternoon.
In addition, any forward-looking statements represent the company's views only as of today and should not be relied upon as representing the company's views as of subsequent date. While the company may elect to update these forward-looking statements at some point in the future, the company specifically disclaims any obligation to do so, even if its views change....
Trevi Therapeutics, Inc. (TRVI) Q4 2023 Earnings Call Transcript